Today, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S … Read More
An FDA vaccine advisory committee on Friday cleared the way for authorization of a third COVID-19 vaccine in the U.S. The committee voted unanimously (22–0) that the benefits of … Read More
the Pfizer-BioNTech BNT162b2 mRNA vaccine appears to be over 90% effective against COVID-19 in the real-world setting — consistent with results from the vaccine’s phase 3 clinical trial — … Read More
Johnson & Johnson’s single-dose vaccine, known as Ad26.COV2.S, offers significant protection against COVID-19, according to an FDA analysis posted in advance of Friday’s vaccine advisory committee meeting. The vaccine … Read More
Some patients with severe COVID-19 have eye abnormalities, according to a study in Radiology. Researchers studied nearly 130 patients hospitalized with severe COVID-19 who had undergone brain MRI. Some 7% … Read More
The Pfizer-BioNTech and Moderna COVID-19 vaccines show reduced effectiveness in neutralizing the highly transmissible SARS-CoV-2 variant B.1.351 that was first identified in South Africa, according to serum analyses published … Read More
An intranasal spray with an engineered peptide successfully prevented ferrets from being infected with SARS-CoV-2, according to a study in Science. Researchers developed a lipopeptide to prevent the coronavirus from attaching … Read More
Enrollment has begun to test additional investigational drugs in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) program. ACTIV is a public-private partnership program to create a coordinated research strategy that … Read More
The CDC now says that people who’ve received either authorized COVID-19 vaccine do not need to quarantine after exposure to a person with COVID-19, provided they meet all of … Read More
The World Health Organization on Wednesday issued an interim recommendation in favor of the AstraZeneca-Oxford adenovirus-vectored COVID-19 vaccine. The agency advises that adults aged 18 and older receive two … Read More
